Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Beijing Double-Crane Buys Transfusion Maker Huali

publication date: Dec 23, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Beijing Double-Crane Pharma announced a small acquisition, saying it will pay 110 million RMB ($17.4 million) to buy Henan Shuanghe Huali Pharma. The purchase will increase Double-Crane’s market share in transfusion products. Huali makes large volume injections, granular formulations and hard capsules. More details....

Stock Symbol: (SHA: 600062)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners